vs
Boxlight Corp(BOXL)与STANDARD BIOTOOLS INC.(LAB)财务数据对比。点击上方公司名可切换其他公司
Boxlight Corp的季度营收约是STANDARD BIOTOOLS INC.的1.5倍($29.3M vs $19.6M),Boxlight Corp净利率更高(-21.1% vs -177.4%,领先156.3%),STANDARD BIOTOOLS INC.同比增速更快(-11.5% vs -19.2%),过去两年STANDARD BIOTOOLS INC.的营收复合增速更高(-12.2% vs -23.1%)
Boxlight Corp是全球互动技术解决方案供应商,主营交互式平板显示器、投影仪、协作软件及教育技术配件,主要服务K12、高等教育机构及企业、政府客户,产品覆盖北美、欧洲、亚太等市场,专注提升教学及协作效率。
Standard BioTools(原Fluidigm公司)是一家美国生命科学工具企业,主营流式细胞术与组织成像分析用质谱流式系统,以及配套的检测试剂盒与试剂,同时供应自动化基因组分析仪器、各类微流控芯片(又称集成流体电路)及配套试剂耗材,全系列产品及应用场景均可提供定制检测方案与相关服务。
BOXL vs LAB — 直观对比
营收规模更大
BOXL
是对方的1.5倍
$19.6M
营收增速更快
LAB
高出7.7%
-19.2%
净利率更高
BOXL
高出156.3%
-177.4%
两年增速更快
LAB
近两年复合增速
-23.1%
损益表 — Q3 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $29.3M | $19.6M |
| 净利润 | $-6.2M | $-34.7M |
| 毛利率 | 29.1% | 48.5% |
| 营业利润率 | -13.4% | -168.5% |
| 净利率 | -21.1% | -177.4% |
| 营收同比 | -19.2% | -11.5% |
| 净利润同比 | -102.0% | -28.8% |
| 每股收益(稀释后) | $-1.88 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BOXL
LAB
| Q3 25 | $29.3M | $19.6M | ||
| Q2 25 | $30.9M | $21.8M | ||
| Q1 25 | — | $40.8M | ||
| Q4 24 | $24.0M | — | ||
| Q3 24 | $36.3M | $22.1M | ||
| Q2 24 | $38.5M | $22.5M | ||
| Q1 24 | $37.1M | $45.5M | ||
| Q4 23 | $38.8M | $28.2M |
净利润
BOXL
LAB
| Q3 25 | $-6.2M | $-34.7M | ||
| Q2 25 | $-4.7M | $-33.5M | ||
| Q1 25 | — | $-26.0M | ||
| Q4 24 | $-16.7M | — | ||
| Q3 24 | $-3.1M | $-26.9M | ||
| Q2 24 | $-1.5M | $-45.7M | ||
| Q1 24 | $-7.1M | $-32.2M | ||
| Q4 23 | $-17.7M | $-19.8M |
毛利率
BOXL
LAB
| Q3 25 | 29.1% | 48.5% | ||
| Q2 25 | 35.0% | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | 30.6% | — | ||
| Q3 24 | 33.8% | 54.9% | ||
| Q2 24 | 37.7% | 46.1% | ||
| Q1 24 | 34.5% | 53.1% | ||
| Q4 23 | 31.7% | 47.6% |
营业利润率
BOXL
LAB
| Q3 25 | -13.4% | -168.5% | ||
| Q2 25 | -12.7% | -118.1% | ||
| Q1 25 | — | -80.8% | ||
| Q4 24 | -67.6% | — | ||
| Q3 24 | -2.4% | -120.9% | ||
| Q2 24 | 3.2% | -134.5% | ||
| Q1 24 | -9.7% | -132.2% | ||
| Q4 23 | -42.8% | -75.9% |
净利率
BOXL
LAB
| Q3 25 | -21.1% | -177.4% | ||
| Q2 25 | -15.3% | -153.7% | ||
| Q1 25 | — | -63.8% | ||
| Q4 24 | -69.6% | — | ||
| Q3 24 | -8.4% | -122.0% | ||
| Q2 24 | -3.8% | -203.3% | ||
| Q1 24 | -19.1% | -70.6% | ||
| Q4 23 | -45.5% | -70.2% |
每股收益(稀释后)
BOXL
LAB
| Q3 25 | $-1.88 | $-0.09 | ||
| Q2 25 | $-1.53 | $-0.09 | ||
| Q1 25 | — | $-0.07 | ||
| Q4 24 | $-87.29 | — | ||
| Q3 24 | $-1.72 | $-0.07 | ||
| Q2 24 | $-0.92 | $-0.12 | ||
| Q1 24 | $-0.76 | $-0.27 | ||
| Q4 23 | $-19.01 | $-0.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $11.8M | $129.4M |
| 总债务越低越好 | $36.7M | — |
| 股东权益账面价值 | $-19.5M | $399.7M |
| 总资产 | $99.6M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
BOXL
LAB
| Q3 25 | $11.8M | $129.4M | ||
| Q2 25 | $7.6M | $158.6M | ||
| Q1 25 | — | $150.9M | ||
| Q4 24 | $8.0M | — | ||
| Q3 24 | $10.5M | $210.6M | ||
| Q2 24 | $7.5M | $269.8M | ||
| Q1 24 | $11.8M | $287.1M | ||
| Q4 23 | $17.3M | $51.7M |
总债务
BOXL
LAB
| Q3 25 | $36.7M | — | ||
| Q2 25 | $39.0M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $37.1M | — | ||
| Q3 24 | $38.8M | $55.2M | ||
| Q2 24 | $40.3M | $55.1M | ||
| Q1 24 | $38.5M | $55.0M | ||
| Q4 23 | $40.2M | $63.5M |
股东权益
BOXL
LAB
| Q3 25 | $-19.5M | $399.7M | ||
| Q2 25 | $-20.6M | $424.5M | ||
| Q1 25 | — | $454.6M | ||
| Q4 24 | $-12.9M | — | ||
| Q3 24 | $6.5M | $489.3M | ||
| Q2 24 | $7.5M | $510.3M | ||
| Q1 24 | $9.1M | $577.3M | ||
| Q4 23 | $16.8M | $-148.1M |
总资产
BOXL
LAB
| Q3 25 | $99.6M | $539.6M | ||
| Q2 25 | $99.2M | $557.0M | ||
| Q1 25 | — | $579.6M | ||
| Q4 24 | $115.3M | — | ||
| Q3 24 | $142.9M | $681.5M | ||
| Q2 24 | $141.3M | $708.7M | ||
| Q1 24 | $142.4M | $777.7M | ||
| Q4 23 | $161.8M | $323.1M |
负债/权益比
BOXL
LAB
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.93× | 0.11× | ||
| Q2 24 | 5.38× | 0.11× | ||
| Q1 24 | 4.23× | 0.10× | ||
| Q4 23 | 2.40× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $1.3M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-23.1M |
| 自由现金流率自由现金流/营收 | — | -118.1% |
| 资本支出强度资本支出/营收 | — | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势,按日历期对齐
经营现金流
BOXL
LAB
| Q3 25 | $1.3M | $-22.2M | ||
| Q2 25 | — | $-20.7M | ||
| Q1 25 | — | $-30.3M | ||
| Q4 24 | $1.6M | — | ||
| Q3 24 | $5.2M | $-27.9M | ||
| Q2 24 | $-5.4M | $-39.0M | ||
| Q1 24 | $-1.9M | $-62.5M | ||
| Q4 23 | $3.3M | $-14.1M |
自由现金流
BOXL
LAB
| Q3 25 | — | $-23.1M | ||
| Q2 25 | — | $-22.6M | ||
| Q1 25 | — | $-35.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-30.1M | ||
| Q2 24 | — | $-41.0M | ||
| Q1 24 | — | $-63.3M | ||
| Q4 23 | — | $-14.1M |
自由现金流率
BOXL
LAB
| Q3 25 | — | -118.1% | ||
| Q2 25 | — | -103.6% | ||
| Q1 25 | — | -86.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -136.4% | ||
| Q2 24 | — | -182.2% | ||
| Q1 24 | — | -138.9% | ||
| Q4 23 | — | -50.2% |
资本支出强度
BOXL
LAB
| Q3 25 | — | 4.5% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | — | 1.7% | ||
| Q4 23 | — | 0.3% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BOXL
| Products | $27.4M | 93% |
| Services | $2.0M | 7% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |